Intelligence ยท Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors โ phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text โ searchable for business development and competitive intelligence.
-
Routine Medication
The First People's Hospital of Lianyungang
Generalized Anxiety Disorder
1 trial -
SCOUT-Assisted Review Workflow
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Coronary Heart Disease (CHD)
1 trial -
SLE group
The First People's Hospital of Lianyungang
Lupus Nephritis
1 trial -
SSRI treated group
Samsung Bioepis NL B.V.
Depression
2 trials -
Senl_B19 autologous CAR-T (S1904) treatment
The First People's Hospital of Lianyungang
Relapsed Adult ALL
1 trial -
Short course palliative radiation.
Hospital Authority, Hong Kong
Cervical Cancer
1 trial -
Sildenafil 100 MG
The First People's Hospital of Lianyungang
Central Venous Pressure
1 trial -
Stapokibart
The First People's Hospital of Lianyungang
Primary Cutaneous Amyloidosis
1 trial -
Study subjects will be vaccinated with 3 (three) vaccine doses. The first vaccine will be administered intramuscularly starting at 6-12 weeks of age followed by two doses at four-week interval
Biotech Pharmaceutical Co.,
Diphtheria
1 trial -
Sucrose Iron๏ผsubcutaneous recombinant human erythropoietin๏ผintravenous vitamin C
The First People's Hospital of Lianyungang
Anemia
1 trial -
T, 260 mg/m2, paclitaxel for injection (albumin-bound)
The First People's Hospital of Lianyungang
Breast Cancer
1 trial -
TCM+ Routine Therapy
The First People's Hospital of Lianyungang
Proteinuria
1 trial -
Tests of the expression of CXCL3 in various tissues
The First People's Hospital of Lianyungang
Diabetic Kidney Disease (DKD)
1 trial -
Thermal stress and performance without a pre-cooling protocol
Petros Pharmaceuticals
Risk of Heat Stress
1 trial -
Topical compound tripterygium
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Active Rheumatoid Arthritis
1 trial -
Total intravenous anesthesia group
Xuzhou Medical University
Balanced Anesthesia
1 trial -
Triferdine
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co.,
Pregnancy Related
1 trial -
Tumour Biopsy and Venous Blood Tests
United Therapeutics Europe Ltd
Soft Tissue Sarcoma
1 trial -
Ultrasound Elastography
Jazz Pharmaceuticals Ireland Limited
Bone Marrow Transplant Complications
1 trial -
Western therapy
Chinese University of Hong Kong
Hand, Foot and Mouth Disease
1 trial -
Wheat Soy Blend Plus Plus (WSB++) with nutrition counselling
United Therapeutics Europe Ltd
Moderate Acute Malnutrition
1 trial -
Whole peanuts without skins, Peanut butter, or no peanuts (control)
United Therapeutics Europe Ltd
Type 2 Diabetes Mellitus
1 trial -
Yishen Qutong Granules
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Esophageal Squamous Cell Carcinoma (ESCC)
1 trial -
ZhenQi BuXue KouFuYe
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Menstrual Disorders
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1โ3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync โ verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources